Dahlia Biosciences
Latest round
- Seed
Last raised
- Nov 2017
Total raised
- Undisclosed
Investors
- 2
About Dahlia Biosciences
Founded in 2017 and based in California, US, Dahlia Biosciences, Inc. is a biotechnology company that develops single-cell RNA analysis tools for diagnostic and research applications.
Who invested in Dahlia Biosciences
2 investors across 1 round
See all investors in Dahlia Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 7, 2017
Amount
Undisclosed
Investors
Questions about Dahlia Biosciences
Who invested in Dahlia Biosciences?
Dahlia Biosciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dahlia Biosciences raised?
Dahlia Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Dahlia Biosciences last raise money?
Dahlia Biosciences's most recent round on record is a Seed, in Nov 2017.
What does Dahlia Biosciences do?
Founded in 2017 and based in California, US, Dahlia Biosciences, Inc.
Where is Dahlia Biosciences headquartered?
Dahlia Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like Dahlia Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dahlia Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Dahlia Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.